The acquisition of Naturwohl by Perrigo marks a major categorical advancement for the organization’s European self-care division. The strategic logic of this transaction hinges on a "category-entry" maneuver, merging the target’s technical operational depth in the weight management and dietary supplement space with the acquirer’s established pan-European distribution network and the commercial infrastructure of Omega Pharma. This structural alignment provides the combined entity with the marketing hardware and scientific talent necessary to address the increasing consumer demand for preventative health and nutritional optimization.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 13.3x since the beginning of 2026, 1.5% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.